The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Demoralization and depression in pancreatic cancer patients.
 
Jar-Yee Liu
No Relationships to Disclose
 
Veronica Placencio-Hickok
Patents, Royalties, Other Intellectual Property - Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst); Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst)
 
Brian Anderson
No Relationships to Disclose
 
Paul Eliezer Oberstein
Consulting or Advisory Role - BTG; BTG; BTG; BTG; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck; Purdue Pharma; Purdue Pharma; Purdue Pharma; Purdue Pharma; TYME; TYME; TYME; TYME
Research Funding - Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck; Merck; Merck; Merck
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme; Merrimack; Merrimack; Merrimack; Merrimack; Seagen; Seagen; Seagen; Seagen
Research Funding - AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme
 
Crystal S. Denlinger
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst)
 
Jun Gong
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants; Clinical Congress Consultants
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Perthera; Perthera; Perthera; Perthera
Research Funding - Ipsen; Ipsen; Ipsen; Ipsen
Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme